GSA Capital Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-30,114
Closed -$88K 1484
2020
Q2
$88K Sell
30,114
-37,723
-56% -$110K 0.05% 500
2020
Q1
$191K Buy
67,837
+55,702
+459% +$157K 0.05% 771
2019
Q4
$39K Sell
12,135
-52,619
-81% -$169K ﹤0.01% 1375
2019
Q3
$140K Sell
64,754
-150,329
-70% -$325K 0.02% 1236
2019
Q2
$675K Sell
215,083
-22,430
-9% -$70.4K 0.08% 478
2019
Q1
$884K Sell
237,513
-7,187
-3% -$26.7K 0.09% 355
2018
Q4
$710K Sell
244,700
-84,400
-26% -$245K 0.08% 377
2018
Q3
$866K Sell
329,100
-101,000
-23% -$266K 0.05% 766
2018
Q2
$1.01M Buy
430,100
+37,824
+10% +$88.5K 0.05% 748
2018
Q1
$1.15M Buy
392,276
+35,095
+10% +$103K 0.06% 566
2017
Q4
$979K Sell
357,181
-343,900
-49% -$943K 0.06% 607
2017
Q3
$2.38M Sell
701,081
-93,200
-12% -$316K 0.16% 104
2017
Q2
$1.96M Sell
794,281
-828,500
-51% -$2.05M 0.13% 165
2017
Q1
$3.68M Buy
1,622,781
+35,025
+2% +$79.5K 0.2% 62
2016
Q4
$3.37M Buy
1,587,756
+66,532
+4% +$141K 0.2% 55
2016
Q3
$5.1M Buy
1,521,224
+199,073
+15% +$667K 0.27% 23
2016
Q2
$4.15M Buy
1,322,151
+417,127
+46% +$1.31M 0.23% 34
2016
Q1
$3.01M Sell
905,024
-36,712
-4% -$122K 0.19% 67
2015
Q4
$3.33M Buy
941,736
+228,013
+32% +$807K 0.16% 101
2015
Q3
$3.59M Sell
713,723
-241,130
-25% -$1.21M 0.18% 78
2015
Q2
$6.14M Buy
954,853
+390,418
+69% +$2.51M 0.24% 37
2015
Q1
$3.97M Buy
564,435
+237,251
+73% +$1.67M 0.16% 88
2014
Q4
$2.52M Buy
327,184
+607
+0.2% +$4.68K 0.18% 86
2014
Q3
$2.44M Buy
326,577
+83,705
+34% +$625K 0.13% 157
2014
Q2
$2.35M Buy
242,872
+108,800
+81% +$1.05M 0.11% 200
2014
Q1
$1.11M Buy
134,072
+15,784
+13% +$131K 0.08% 284
2013
Q4
$998K Sell
118,288
-141,513
-54% -$1.19M 0.08% 359
2013
Q3
$2.07M Buy
259,801
+35,343
+16% +$282K 0.16% 115
2013
Q2
$1.73M Buy
+224,458
New +$1.73M 0.21% 86